Breast CancerNCT07820124
Digital Education for Breast Cancer Screening Beliefs and Prevention Behaviors
A study testing Instagram-Based Breast Cancer Education, Website-Based Breast Cancer Education and E-Brochure Breast Cancer Education in people with Breast Cancer, run by Gümüşhane Universıty at 1 site in Turkey (Türkiye).
Trial summary
This randomized study compared three ways of delivering standardized digital education about breast cancer and early detection among adult women. Participants were assigned to education through a private social media account, a dedicated website, an electronic brochure delivered through WhatsApp, or a control group. Read more about this study
- Who is it for?
- Ages 20 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Breast Cancer
- What is being tested?
- Instagram-Based Breast Cancer Education, Website-Based Breast Cancer Education and E-Brochure Breast Cancer Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jun 2022to 31 Dec 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Female
- Aged 20 years or older
- Able to read Turkish
- Consistent internet access
- Provided electronic informed consent
Who cannot join
- Could not be reached during the study
- Visual, hearing, or speech impairments that prevented participation
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Gumushane University
Gümüşhane, Gümüşhane Province, 29100
About this study
Official title: Comparative Effects of Social Media, Website, and E-Brochure Education on Breast Cancer Screening Beliefs and Prevention Behaviors: A Four-Arm Randomized Controlled Trial
This randomized study compared three ways of delivering standardized digital education about breast cancer and early detection among adult women. Participants were assigned to education through a private social media account, a dedicated website, an electronic brochure delivered through WhatsApp, or a control group. The study assessed whether the educational formats changed breast cancer screening beliefs and prevention behaviors after 12 weeks.
Read the detailed description
A total of 120 women were allocated equally to four parallel groups (30 per group) using a computer-generated block randomization sequence. The three intervention groups received the same core breast cancer and early-detection information adapted to Instagram, a website, or an electronic brochure, together with weekly platform-specific reminders for 12 weeks. The control group received no active digital education during the study period. Outcomes were measured at baseline and after 12 weeks using the Breast Cancer Screening Beliefs Scale and the Scale of Factors Affecting Women's Breast Cancer Prevention Behaviors.
- Conditions
- Breast Cancer
- Being tested
- Instagram-Based Breast Cancer Education, Website-Based Breast Cancer Education, E-Brochure Breast Cancer Education
- Keywords
- Health Education, Breast Cancer Screening, Digital Health, Social Media, Prevention Behaviors
- Medical subject headings
- Breast Neoplasms, Health Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Instagram-Based Breast Cancer EducationBehavioural
Standardized breast cancer and early-detection education delivered through interactive posts, stories, and short videos on a private Instagram account, with weekly reminders for 12 weeks.
Website-Based Breast Cancer EducationBehavioural
Standardized breast cancer and early-detection education delivered through a dedicated website, with weekly reminders for 12 weeks.
E-Brochure Breast Cancer EducationBehavioural
Standardized breast cancer and early-detection education delivered as an electronic brochure through WhatsApp, with weekly reminders for 12 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Social Media Education | Experimental | Participants accessed interactive posts, stories, and short videos through a private Instagram account and received weekly reminders for 12 weeks. Receives: Behavioral: Instagram-Based Breast Cancer Education |
| Website Education | Experimental | Participants accessed a dedicated website containing standardized breast cancer and screening information and received weekly reminders for 12 weeks. Receives: Behavioral: Website-Based Breast Cancer Education |
| E-Brochure Education | Experimental | Participants received a standardized electronic brochure through WhatsApp and weekly reminders for 12 weeks. Receives: Behavioral: E-Brochure Breast Cancer Education |
| Control | No intervention | Participants received no active digital education during the 12-week study period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change From Baseline in Breast Cancer Screening Beliefs Scale Total Score
The Breast Cancer Screening Beliefs Scale measures attitudes toward health screening, knowledge and perceptions of breast cancer, and perceived barriers to mammography. The outcome is the change in total score from baseline to post-intervention; higher scores indicate more favorable screening beliefs.
Measured: Baseline and 12 weeks
Change From Baseline in Women's Breast Cancer Prevention Behaviors Scale Total Score
The Scale of Factors Affecting Women's Breast Cancer Prevention Behaviors assesses support systems, self-efficacy, self-care, stress management, motivation, information seeking, and attitude. The outcome is the change in total score from baseline to post-intervention; higher scores indicate more favorable prevention behaviors.
Measured: Baseline and 12 weeks
Secondary outcomes (1)
Change From Baseline in BCSB and WBCPB Subscale Scores
Changes in the Breast Cancer Screening Beliefs Scale subscales (attitudes toward health screening, knowledge and perceptions of breast cancer, and barriers to mammography) and the Women's Breast Cancer Prevention Behaviors Scale subscales (support systems, self-efficacy, self-care, stress management, motivation, information seeking, and attitude).
Measured: Baseline and 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2026
- Study start1 Jun 2022
- Primary completion31 Dec 2022
- Study completion31 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 120 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gümüşhane Universıty
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aydanur Aydin, Gümüşhane Universıty
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07820124
- Sponsor's protocol ID
- GumushaneUni11
- Status last verified
- Sep 2026
- First submitted
- 9 Sep 2026
- Last updated
- 15 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data underlying the results reported in the publication may be shared.
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Effects of Social Media, Website, and E-Brochure Education on Breast Cancer Screening Beliefs and Prevention Behaviors: A Four-Arm Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07820124
- Acronym / sponsor ID
- GumushaneUni11
- Conditions
- Breast Cancer
- Keywords
- Health Education, Breast Cancer Screening, Digital Health, Social Media, Prevention Behaviors
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 120 participants (actual)
- Lead sponsor
- Gümüşhane UniversıtyUniversity, hospital or other
- Study start
- 1 Jun 2022 (actual)
- Primary completion
- 31 Dec 2022 (actual)
- Study completion
- 31 Dec 2022 (actual)
- First posted
- 15 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized study compared three ways of delivering standardized digital education about breast cancer and early detection among adult women. Participants were assigned to education through a private social media account, a dedicated website, an electronic brochure delivered through WhatsApp, or a control group. The study assessed whether the educational formats changed breast cancer screening beliefs and prevention behaviors after 12 weeks.
Detailed description
A total of 120 women were allocated equally to four parallel groups (30 per group) using a computer-generated block randomization sequence. The three intervention groups received the same core breast cancer and early-detection information adapted to Instagram, a website, or an electronic brochure, together with weekly platform-specific reminders for 12 weeks. The control group received no active digital education during the study period. Outcomes were measured at baseline and after 12 weeks using the Breast Cancer Screening Beliefs Scale and the Scale of Factors Affecting Women's Breast Cancer Prevention Behaviors.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Social Media Education | Experimental | Behavioral: Instagram-Based Breast Cancer EducationParticipants accessed interactive posts, stories, and short videos through a private Instagram account and received weekly reminders for 12 weeks. |
| Website Education | Experimental | Behavioral: Website-Based Breast Cancer EducationParticipants accessed a dedicated website containing standardized breast cancer and screening information and received weekly reminders for 12 weeks. |
| E-Brochure Education | Experimental | Behavioral: E-Brochure Breast Cancer EducationParticipants received a standardized electronic brochure through WhatsApp and weekly reminders for 12 weeks. |
| Control | No intervention | –Participants received no active digital education during the 12-week study period. |
Who may qualify
- Ages
- 20 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Female
- Aged 20 years or older
- Able to read Turkish
- Consistent internet access
- Provided electronic informed consent
Key exclusion criteria (2 listed)
- Could not be reached during the study
- Visual, hearing, or speech impairments that prevented participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Instagram-Based Breast Cancer EducationStandardized breast cancer and early-detection education delivered through interactive posts, stories, and short videos on a private Instagram account, with weekly reminders for 12 weeks. | Behavioural | Social Media Education |
| Website-Based Breast Cancer EducationStandardized breast cancer and early-detection education delivered through a dedicated website, with weekly reminders for 12 weeks. | Behavioural | Website Education |
| E-Brochure Breast Cancer EducationStandardized breast cancer and early-detection education delivered as an electronic brochure through WhatsApp, with weekly reminders for 12 weeks. | Behavioural | E-Brochure Education |
Primary outcome
Change From Baseline in Breast Cancer Screening Beliefs Scale Total Score
Time frame: Baseline and 12 weeks
The Breast Cancer Screening Beliefs Scale measures attitudes toward health screening, knowledge and perceptions of breast cancer, and perceived barriers to mammography. The outcome is the change in total score from baseline to post-intervention; higher scores indicate more favorable screening beliefs.
Change From Baseline in Women's Breast Cancer Prevention Behaviors Scale Total Score
Time frame: Baseline and 12 weeks
The Scale of Factors Affecting Women's Breast Cancer Prevention Behaviors assesses support systems, self-efficacy, self-care, stress management, motivation, information seeking, and attitude. The outcome is the change in total score from baseline to post-intervention; higher scores indicate more favorable prevention behaviors.
1 secondary outcome
Change From Baseline in BCSB and WBCPB Subscale Scores
Time frame: Baseline and 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2026.
- Individual participant dataSharing planned: Yes. De-identified individual participant data underlying the results reported in the publication may be shared.
Related trials for Breast Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Instagram-Based Breast Cancer Education, Website-Based Breast Cancer Education and E-Brochure Breast Cancer Education in people with Breast Cancer, run by Gümüşhane Universıty at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change From Baseline in Breast Cancer Screening Beliefs Scale Total Score (time frame: Baseline and 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2026.